SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000905718-18-000851
Filing Date
2018-10-16
Accepted
2018-10-16 16:26:12
Documents
2
Period of Report
2018-10-15

Document Format Files

Seq Description Document Type Size
1 matinasbiofm3_oct152018.html 3  
1 matinasbiofm3_oct152018.xml 3 1615
2 POWER OF ATTORNEY poa_matkovits.htm EX-24 7102
  Complete submission text file 0000905718-18-000851.txt   10105
Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-443-1860
Matinas BioPharma Holdings, Inc. (Issuer) CIK: 0001582554 (see all company filings)

IRS No.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ARADIGM CORPORATION 3929 POINT EDEN WAY HAYWARD CA 94545
Business Address
Matkovits Theresa (Reporting) CIK: 0001745393 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38022 | Film No.: 181124683